LHRCDA: Predicting associations between circRNA and drug sensitivity via learnable hypergraph reconstruction.

Area of Science:

• Bioinformatics
• Computational Biology
• Genomics

Background:

• Circular RNAs (circRNAs) are crucial in disease development and drug response, making their association with drugs significant for understanding disease mechanisms and finding therapeutic targets.
• Traditional hypergraph methods struggle with dynamic structure adjustment and extracting higher-order information, limiting their effectiveness in complex biological network analysis.

Purpose of the Study:

• To develop an advanced computational model for predicting circRNA-drug sensitivity associations.
• To overcome the limitations of static hypergraph methods by incorporating learnable reconstruction and hierarchical mapping for enhanced information extraction.

Main Methods:

• Introduced a Learnable Hypergraph Reconstruction approach for circRNA-drug sensitivity association prediction (LHRCDA).
• Employed matrix decomposition for hypergraph initialization, followed by a learnable reconstruction mechanism to capture higher-order structural information.
• Utilized a hierarchical hypergraph mapping and perceptual fusion strategy to integrate heterogeneous graph and hypergraph views, enhancing nonlinear interaction modeling.

Main Results:

• The LHRCDA model demonstrated superior performance in predicting circRNA-drug sensitivity associations compared to existing state-of-the-art methods.
• Higher-order structural modeling via hypergraphs significantly improved prediction accuracy.
• Case studies on vorinostat and cetuximab validated the model's potential as a reliable tool for drug discovery.

Conclusions:

• The LHRCDA approach effectively models complex circRNA-drug interactions by leveraging learnable hypergraph reconstruction and hierarchical fusion.
• This method offers a promising computational tool for identifying novel circRNA-drug sensitivity associations, aiding in disease mechanism elucidation and therapeutic target discovery.